Babar, Z. and Areesha Babar 2025. FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care. Journal of the Pakistan Medical Association. 75, 07 (Jul. 2025), 1156–1156. DOI:https://doi.org/10.47391/JPMA.21951.